Page 10 - Sohini Das

Insulin's century-old legacy still stands tall amid new diabetes drugs

Despite the rise of GLP-1s and oral therapies, insulin remains vital for millions, particularly those with type 1 diabetes and other insulin-dependent conditions

SUV, tractor fire up M&M earnings, Q4 PAT up 20% at Rs 3,295 crore

Company plans greenfield PV plant by FY28 as SUV capacity runs past 90%

Medicines are just one part of the solution: Zydus' Sharvil Patel

Zydus MD Sharvil Patel says the company is going beyond pharma into med-tech, diagnostics, and rare diseases, aiming for a global footprint while retaining India as the manufacturing hub

Old is gold: Pre-owned luxury cars outsell new in 2024 as demand surges

The overall Indian automotive market is moving towards premiumisation, a trend evident from the rising share of utility vehicles (UVs)

New Maharashtra EV policy aims to strengthen charging infrastructure

With outlay of ₹1,995 cr, state is targeting 30% EV registrations by 2030

Stake in SML Isuzu, M&M eyes e-bus foray soon, 21% share in LCV bus segment

M&M has entered into an agreement to acquire 58.96% in SML Isuzu for Rs 555 crore

Drugmakers Glenmark Pharma, Cipla plan to step up US manufacturing

The US already contributes a significant share, around a quarter, of Cipla's total revenues

Glenmark's research arm will be self-funded soon, says Glenn Saldanha

Pharma major evaluating opportunities to out-license key cancer asset ISB-2001, deal likely in H1CY25

Booster dose: India inches closer to regulatory framework for OTC drugs

DTAB has accepted sub-panel recommendation on OTC drugs list

IPO-bound Ather Energy banks on upcoming Maharashtra unit for growth

Sets price band of Rs 304-321 per share for IPO which opens on April 28

M&M rejigs leadership team as Mahindra Logistics CEO Ram Swaminathan quits

Hemant Sikka to head Mahindra Logistics, Veejay Nakra to head farm biz, R Veluswamy to head auto division

Skoda Auto India gears up for electric vehicle play with local push

Kylaq success fuels confidence as carmaker eyes exports, higher India mkt share

Results preview: Domestic dose likely to ease US drag for pharma firms

Nuvama Institutional Equities said therapies like antidiabetic, anti-infective and respiratory had underperformed in the Indian pharma market

PV sales up 2% in FY25 on utility vehicle demand, says industry group

Most segments clock growth, commercial vehicle numbers decline: SIAM

Industry bodies seek immediate safeguards against influx of Chinese goods

Want govt to enforce anti-dumping duties, warn of mill closures and job losses

DRL trims workforce costs by 25% amid Revlimid-linked margin strain

There are 21,757 permanent employees on company rolls as on March 31, 2024; cost optimisation to offset margin pressure due to declining Revlimid sales

Sun Pharma stock up 2.15% as US court clears alopecia drug launch

According to market estimates, Leqselvi is projected to contribute $90 million to Sun Pharma's sales in FY26, and $125 million in FY27

Luxury car sales hit record in FY25; FY26 outlook remains cautious

The overall luxury car market had grown by around 3 per cent in FY25

US tops India's pharma exports with $9.8 bn share in April-Feb FY25

Despite looming tariffs, shipments to US grew 14%; EU and Africa next on the pharma export map

Chetak top-selling electric two-wheeler in Q4FY25, says Bajaj Auto

The Chetak was originally introduced in the 1970s, when it had a strong presence in the Indian scooter market for several decades